| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	 
																	Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabli...
 
																	
 
																	Goldman Sachs analyst Paul Choi downgrades Lantheus Holdings (NASDAQ:LNTH) from Buy to Neutral and lowers the price target f...
 
																	 
																	
 
																	B. Riley Securities analyst Justin Walsh maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and lowers the price target fr...
 
																	TD Cowen analyst Tara Bancroft maintains Lantheus Holdings (NASDAQ:LNTH) with a Buy and lowers the price target from $95 to ...
 
																	Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...